Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 11:23 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 697–720 of 1,131 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Functional MRI Clear all

Conditions: Deliberate Self Harm
Interventions: N-Acetylcysteine, fMRI; Dietary Supplement · Drug
Lead sponsor: University of Minnesota; Other
Eligibility: 13 Years to 21 Years
Enrollment: 67 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2015
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Primary Cervical Dystonia, DYT 1 Dystonia
Interventions: Primary Cervical Dystonia (Trihexyphenidyl), Controls Primary Cervical Dystonia (Trihexyphenidyl), DYT 1 Dystonia (Healthy Control), DYT 1 Dystonia; Drug · Other
Lead sponsor: University of Florida; Other
Eligibility: 7 Years to 70 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Chronic Obstructive Pulmonary Disease
Interventions: Hyperpolarized 129Xe gas; Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 20 Years to 75 Years
Enrollment: 1 participant
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Schizophrenia, Memory Disorders, Cognition Disorders
Interventions: Atomoxetine, Functional magnetic resonance imaging, Neuropsychological Testing, Placebo; Drug · Procedure
Lead sponsor: National Institute of Mental Health (NIMH); NIH
Eligibility: 18 Years to 45 Years
Enrollment: 11 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2011
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Parkinson Disease
Interventions: Not listed
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: 21 Years and older
Enrollment: 133 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2002 – 2009
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Moderate to Severe Chronic Pain
Interventions: NKTR-181, Oxycodone IR; Drug
Lead sponsor: Nektar Therapeutics; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 8 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Abnormalities, Imaging, Patellofemoral Pain Syndrome
Interventions: Not listed
Lead sponsor: National Institutes of Health Clinical Center (CC); NIH
Eligibility: 5 Years to 95 Years
Enrollment: 750 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2003
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Cognitive Performance
Interventions: Cerebellar transcranial magnetic stimulation; Device
Lead sponsor: Johns Hopkins University; Other
Eligibility: 19 Years to 30 Years
Enrollment: 17 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2000 – 2005
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Depressive Disorder, Major
Interventions: Not listed
Lead sponsor: National Institute of Mental Health (NIMH); NIH
Eligibility: 18 Years to 50 Years
Enrollment: 95 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004 – 2014
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Healthy, Caffeine, Adenosine, Dopamine D2/3 Receptor Availability
Interventions: Caffeine (200 mg), Placebo; Drug
Lead sponsor: Hsiao-Ying Wey; Other
Eligibility: 18 Years to 45 Years
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Charlestown, Massachusetts

Conditions: Posttraumatic Stress Disorder
Interventions: Midomafetamine, Therapy; Drug · Behavioral
Lead sponsor: Resilient Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Mt. Pleasant, South Carolina

Conditions: Social Behavior
Interventions: Metta meditation; Behavioral
Lead sponsor: Georgetown University; Other
Eligibility: 18 Years to 55 Years
Enrollment: 67 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Social Anxiety Disorder, Body Dysmorphic Disorder
Interventions: Cognitive Behavioral Therapy; Behavioral
Lead sponsor: University of Washington; Other
Eligibility: 18 Years to 45 Years
Enrollment: 160 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Brain Function, Healthy Adults
Interventions: ondansetron, placebo; Drug
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years to 60 Years
Enrollment: 54 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: New York, New York

Conditions: Tinnitus, Subjective
Interventions: Resound Relief smartphone app; Behavioral
Lead sponsor: University of Illinois at Urbana-Champaign; Other
Eligibility: 21 Years to 70 Years
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Urbana, Illinois

Conditions: Chronic Traumatic Brain Injury
Interventions: Anti-inflammatory Diet, N-acetyl Cysteine, Neuro Emotive Technique; Other · Dietary Supplement · Behavioral
Lead sponsor: Thomas Jefferson University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2027
U.S. locations: 2
States / cities: Philadelphia, Pennsylvania • Villanova, Pennsylvania

Conditions: Post Traumatic Stress Disorder
Interventions: Mindfulness-Based Cognitive Therapy, Muscle Relaxation Therapy; Behavioral
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years to 72 Years
Enrollment: 61 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 2
States / cities: Ann Arbor, Michigan • Columbus, Ohio

Conditions: Essential Tremor
Interventions: multi-modality neuroimaging; Device
Lead sponsor: Vibhor Krishna; Other
Eligibility: 40 Years and older
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Healthy Controls, Alcohol Use Disorder
Interventions: Placebo, Oxytocin; Drug
Lead sponsor: University of Utah; Other
Eligibility: 18 Years to 45 Years
Enrollment: 88 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2024
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Autism Spectrum Disorders
Interventions: Oxytocin; Drug
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 6 Years to 18 Years
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Drug Use Disorder, Opioid Dependence, Opioid-Related Disorders, Opioid Use, Opioid Abuse
Interventions: fMRI; Diagnostic Test
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 50 Years
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 2
States / cities: Hartford, Connecticut • New Haven, Connecticut

Conditions: Posttraumatic Stress Disorder
Interventions: Mindfulness & Compassion Meditation-based Exposure Therapy, Present Centered Therapy for PTSD; Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 21 Years to 50 Years · Male only
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 2
States / cities: Ann Arbor, Michigan

Conditions: Healthy Adult Women
Interventions: 1-Fermented Dairy Product (test), 2-Milk-based non-fermented dairy product(control); Other
Lead sponsor: Danone Global Research & Innovation Center; Industry
Eligibility: 18 Years to 60 Years · Female only
Enrollment: 51 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Stress
Interventions: Placebo, Oxytocin Intranasal Spray 12 International Unit (12IU), Oxytocin Intranasal Spray 24 International Unit (24IU), Functional MRI; Drug · Procedure
Lead sponsor: University of Nebraska; Other
Eligibility: 50 Years and older · Female only
Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Omaha, Nebraska

Search by objective public record fields.

Early Study of N-Acetylcysteine to Treat Deliberate Self-Harm in Adolescents

Neuroimaging of Dystonia

Functional Applications of Hyperpolarized 129Xe MRI

The Effects of Atomoxetine on Cognition and Brain Function Based on Catechol-O-methyltransferase(COMT) Genotype

How the Loss of Dopamine and Dopamine-Restoring Medicines Affect Movement Performance

A Study Using fMRI Imaging to Evaluate the Effect of NKTR-181 on Brain Activity in Healthy, Non-physically Dependent Recreational Opioid Users.

MRI Study of Musculoskeletal Function

Effects of Transcranial Magnetic Stimulation to the Cerebellum on Cognition

Effects of Tryptophan Depletion on Brain Processing of Emotions in Patients With Mood Disorders

Effects of Caffeine on Reinforcement Learning in Healthy Adults Using PET/MRI

Exploring Mechanisms of Action in MDMA-assisted Psychotherapy for PTSD

Metta Meditation Training on Prosocial Behavior

Individual Factors of CBT Underlying Success

The Effects of Ondansetron on Brain Function

Evaluating the GN ReSound Relief App Using task-and Rest-based fMRI

PET-MRI in Chronic Traumatic Brain Injury (CTBI)

Neural Mechanisms of Mindfulness-based Cognitive Therapy (MBCT) for Posttraumatic Stress Disorder (PTSD)

Functional Neuroimaging Feedback for Focused Ultrasound Thalamotomy

Deciphering the Role of Oxytocin in Motivation: an fMRI Study. Part II

Brain Imaging of Intranasal Oxytocin Treatment in Autism

fMRI and Opioid Abstinence

Mindfulness and Present Centered Therapies for PTSD: Efficacy and Mechanisms

A f-MRI Study Of Affective Changes Associated With Four Weeks Consumption Of A Fermented Dairy Product In Healthy Women

Intranasal Oxytocin Intervention for Caregivers to Persons With Dementia